Found 18 matching trials
A Global Phase II/III Clinical Study to Evaluate the Efficacy and Safety of HLX43 Monotherapy or HLX43 in Combination With HLX07 Versus Docetaxel in Advanced or Metastatic Squamous Non-Small Cell Lung Cancer PHASE2 This is a randomized, open-label, multi-center, global phase II/III clinica...
Show More Location
Cancer Hospital, Chinese Academy of Medical Sciences
Learn More & Join Trial
Short-Course Radiotherapy Followed by Neoadjuvant Chemotherapy, HLX07and Serplulimab in LARC PHASE2 The study is a multicenter, open-label, phase II clinical study, and the pu...
Show More Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX07 Combination Therapy or Monotherapy in Patients With Advanced ESCC PHASE2 This study is conducted in patients with Locally advanced, unresectable, or...
Show More Location
Cancer Hospital Chinese Academic of Medical Sciences
Learn More & Join Trial
HLX07(Anti-EGFR mAb) in Patients With Advanced or Metastatic Solid Tumors PHASE1 This Phase1, open-label and dose-escalation study will evaluate the safety,...
Show More Location
Fudan University shanghai cancer center
Learn More & Join Trial
HLX07 Combination Therapy or Motherapy in Patient With Advanced Hepatocellular Carcinoma PHASE2 This study is conducted in patients with advanced hepatocellular carcinoma ...
Show More Location
Multiple Locations
Learn More & Join Trial
A Phase Ib/II Study to Evaluate HLX43 Combined With HLX07 or Serplulimab in Patients With Advanced or Metastatic Colorectal Cancer PHASE1 This study is a phase Ib/II study to evaluate the efficacy, safety and tole...
Show More Location
Sun Yat-Sen University Cancer Center
Learn More & Join Trial
Evaluate the Efficacy and Safety of HLX10 in Combination With HLX07 in Patients With Advanced Head and Neck Tumors PHASE2 Part1:
A mutilpe-center, open-label, Phase II clinical trial to evaluate t...
Show More Location
Shanghai Henlius Biotech Inc.
Learn More & Join Trial
Phase II Clinical Study to Compare the Efficacy and Safety of HLX07 + Serplulimab +Chemotherapy Versus Placebo + Serplulimab + Chemotherapy in First-Line Treatment of Patients With Recurrent or Metastatic NPC PHASE2 A Randomized, Double-Blind, Multi-Center Phase II Clinical Study to Compare...
Show More Status
Active Not Recruiting
Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
An Open-label, Phase 1 Study to Determine the Maximum Tolerated Dose of HLX07,in Patients With Advanced Solid Cancers PHASE1 This study is to determine the maximum tolerated dose (MTD) and recommended...
Show More Learn More & Join Trial
A Study of HLX07 + HLX10 With or Without Chemotherapy Versus HLX10 With Chemotherapy in First Line sqNSCLC PHASE2 The purpose of this study is to evaluate the clinical efficacy and safety o...
Show More Location
Guangdong Provincial People's Hospital
Learn More & Join Trial